Pacylex

Pacylex Presents as Medical and Investment Conferences Go Virtual

Edmonton, Alberta, Canada, May 27, 2020 – PACYLEX PHARMACEUTICALS, INC. a pre-IND-stage pharmaceutical company targeting cancers with a new first-in-class therapeutic, announced today that its chief executive officer, Michael

Read More

Recent News

Pacylex

Pacylex Presents as Medical and Investment Conferences Go Virtual

Read More

Pacylex

Pacylex Raises US $3.9 Million To Advance New Cancer Therapy PCLX-001 Towards Clinical Trials

Read More

Pacylex

Pacylex interviewed at the BIO Investor Forum

Read More
1 / 3
Next
Follow Pacylex